Multimodal particle size distributions emitted from HFA-134a solution pressurized metered-dose inhalers
- 1 September 2003
- journal article
- research article
- Published by Springer Nature in AAPS PharmSciTech
- Vol. 4 (3) , 76-86
Abstract
The purpose of this research was to investigate the measurement and in vitro delivery implications of multimodal distributions, occurring near or in the respirable range, emitted from pressurized metered-dose inhalers (pMDIs). Particle size distributions of solution pMDIs containing hydrofluoroalkane-134a (HFA-134a) and ethanol were evaluated using 2 complementary particle-sizing methods: laser diffraction (LD) and cascade impaction (CI). Solution pMDIs were formulated from mixtures of HFA-134a (50%-97.5% wt/wt) and ethanol. A range of propellant concentrations was selected for a range of vapor pressures. The fluorescent probe, Rhodamine B, was included for chemical analysis. The complementary nature of LD and CI allowed identification of 2 dominant particle size modes at 1 and 10 micro m or greater. Increasing propellant concentrations resulted in increases in the proportion of the size distributions at the 1- micro m mode and also reduced the particle size of the larger droplet population. Despite significant spatial differences and time scales of measurement between the particle-sizing techniques, the fine particle fractions obtained from LD and CI were practically identical. This was consistent with LD experiments, which showed that particle sizes did not decrease with increasing measurement distance, and may be explained by the absence of significant evaporation/disintegration of larger droplets. The fine particle fractions (FPFs) emitted from HFA-134a/ethanol solution pMDI can be predicted on the basis of formulation parameters and is independent of measurement technique. These results highlight the importance of presenting particle size distribution data from complementary particle size techniques.Keywords
This publication has 19 references indexed in Scilit:
- Respiratory Deposition Patterns of Salbutamol pMDI with CFC and HFA-134a Formulations in a Human Airway ReplicaJournal of Aerosol Medicine, 2001
- CFC transition: the Emperor's new clothes. Each class of drug deserves a delivery system that meets its own requirementsThorax, 2000
- Effect of formulation parameters on hydrofluoroalkane-beclomethasone dipropionate drug deposition in humans☆☆☆Journal of Allergy and Clinical Immunology, 1999
- Drug–surfactant–propellant interactions in HFA-formulationsInternational Journal of Pharmaceutics, 1999
- Influence of formulation additives on the vapor pressure of hydrofluoroalkane propellantsInternational Journal of Pharmaceutics, 1998
- Surfactant Dissolution and Water Solubilization in Chlorine-Free Liquified Gas PropellantsDrug Development and Industrial Pharmacy, 1998
- An Experimental Investigation of the Spray Issued from a pMDI Using Laser Diagnostic TechniquesJournal of Aerosol Medicine, 1997
- Formulation of solution metered dose inhalers and comparison with aerosols emitted from conventional suspension systemsInternational Journal of Pharmaceutics, 1995
- Safety of PropellantsJournal of Aerosol Medicine, 1995
- Influence of Formulation on Aerosol Particle SizeJournal of Pharmaceutical Sciences, 1969